Global Spinal Implants & Surgery Devices Industry Report 2020 - Medtronic, DePuy Synthes and NuVasive Dominated the Market in 2019 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spinal Implants and Surgery Devices Market by Technology (Fusion, Spine Biologics, VCF, Decompression, Motion Preservation), Product (Thoracic, Cervical, Interbody, Spine Biologics, Non-Fusion, Stimulators), Type (Open, MIS) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global spinal implants and surgery devices market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5%. In 2019, Medtronic (Ireland), DePuy Synthes (US), and NuVasive, Inc. (US) dominated the market.

The major factors driving the growth of this market include advancements in spine surgery technologies, increasing incidence of spinal disorders, the launch of advanced bone grafting products, and the increasing adoption of minimally invasive spine surgeries. However, the high cost of spinal surgery and uncertainties surrounding reimbursement are expected to restrain the growth of this market during the forecast period.

The thoracic fusion & lumbar fusion devices segment accounted for the largest market share in 2019.

Based on product, the spinal implants and surgery devices market is segmented into thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, non-fusion devices, vertebral compression fracture treatment devices, spinal decompression devices, and spine bone stimulators. The thoracic fusion and lumbar fusion devices segment accounted for the largest share of the spinal implants and surgery devices market in 2019. The large share of this segment can be attributed to the increasing incidence of lumbar degenerative disc disease and the growing number of product launches.

The spinal fusion and fixation technologies segment accounted for the largest share of the spinal implants and surgery devices market in 2019.

On the basis of technology, the spinal implants and surgery devices market is segmented into spinal fusion and fixation, vertebral compression fracture treatment, motion preservation/non-fusion, and spinal decompression technologies. The spinal fusion and fixation technologies segment accounted for the largest share of the spinal implants and surgery devices market in 2019. The large share of this segment can be attributed to the rising incidence of target diseases (such as degenerative disc disease and spinal stenosis) with the growing geriatric population across the globe, a growing number of spinal fusion procedures, and technological advancements in spinal fusion techniques and bone grafting procedures.

North America accounted for the largest share of the global spinal implants and surgery devices market in 2019.

The spinal implants and surgery devices market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global spinal implants and surgery devices market in 2019. The large share of the North American market can be attributed to its highly developed healthcare infrastructure and reimbursement systems and high patient awareness and physician education.

Research Coverage

This report studies the spinal implants and surgery devices market based on product, technology, type of surgery, and region. The report also studies the major factors affecting market growth, such as drivers, restraints, opportunities, and challenges. In addition, it analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Market Dynamics

Drivers

• Advancements in Spine Surgery Technologies
• Increasing Incidence of Spinal Disorders
• Launch of Advanced Bone Grafting Products
• Increasing Demand for Minimally Invasive Surgical Procedures

Restraints

• High Cost of Treatment Procedures
• Uncertainty in Reimbursement

Opportunities

• Emerging Markets
• Rising Number of Hospitals and Surgical Centers

Challenges

• Lack of Adequate Physicians and Limited Awareness/Education

Trends

• Market Consolidation

Companies Profiled

• Abbott Laboratories
• B. Braun Melsungen
• Bioventus
• Boston Scientific
• Colfax Corporation
• Depuy Synthes (Subsidiary of Johnson & Johnson)
• Globus Medical
• Implanet
• Kuros Biosciences AG
• Meditech Spine
• Medtronic, PLC
• Nuvasive, Inc.
• Orthofix International N.V.
• RTI Surgical, Inc.
• Seaspine Holdings Corporation
• Spineart
• Stryker Corporation
• Ulrich GmbH & Co. KG
• Zimmer Biomet Holdings, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/ucvup7